Market Tracker

10/24 6:05pm ET

TherapeuticsMD Inc (NYSE MKT LLC:TXMD)

4.25
Data as of Oct 24
 +0.02 / +0.47%
Today’s Change
3.42
Today|||52-Week Range
9.01
-18.43%
Year-to-Date
No recent news for TherapeuticsMD Inc.

Today’s Trading

Previous close4.23
Today’s open4.23
Day’s range4.19 - 4.41
Volume1,390,213
Average volume (3 months)1,436,260
Market cap$662.2M
Dividend yield--
Data as of 4:02pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)+42.11%
Earnings growth (this year)-34.55%
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+129.85%
P/E ratioNM
Price/Sales75.74
Price/Book11.26

Competitors

 Today’s
change
Today’s
% change
DRTXDurata Therapeutics ...-0.04-0.17%
TBPHTheravance Biopharma...-0.58-2.84%
RPTPRaptor Pharmaceutica...+0.09+0.83%
OMEDOncoMed Pharmaceutic...+0.08+0.38%
Data as of 3:59pm ET, 10/24/2014

Financials

Next reporting dateNovember 3, 2014
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$8.8M
Annual profit (last year)-$28.4M
Net profit margin-323.84%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Robert G. Finizio
President, Secretary &
Director
John C. K. Milligan
Corporate headquarters
Boca Raton, Florida

Forecasts